Environmental Matters in the Commonwealth of Kentucky

Responding to recent reports regarding findings of trace levels of pharmaceuticals found in U.S. drinking water supplies, Waters Corporation (NYSE: WAT) has announced that it will offer qualified U.S. water authorities complimentary drinking water analysis for common over-the-counter and prescription antidepressant pharmaceutical compounds to help assess regional exposure and move towards forward-looking solutions. For a limited time, Waters will offer authorized officials from any U.S. water authority that serves more than 100,000 customers to submit a request for a complimentary test for common over-the-counter and anti-depressant pharmaceutical compounds of their finished water (tap water) by visiting http://www.waters.com/h2o.